The 20 Best Autoimmune Hemolytic Anemia Doctors Near Me in San Francisco, CA
Find the Top Autoimmune Hemolytic Anemia Experts and Specialists
The 20 Best Autoimmune Hemolytic Anemia Doctors near San Francisco, CA
MediFind found 27 doctor with experience in Autoimmune Hemolytic Anemia near San Francisco, CA. Of these, 25 are Experienced and 2 are Advanced.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Andrew Leavitt is a Hematologist in San Francisco, California. Dr. Leavitt is rated as an Advanced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Hemophilia A, Von Willebrand Disease (VWD), Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.
General Internal Medicine At Mount Zion
Dr. Janet Chu is an internal medicine specialist who provides primary care to adults. She is dedicated to partnering with her patients and empowering them to achieve their health goals. Chu's research focuses on how factors at the individual, health care system or neighborhood level can lead to disparities in care delivery and patient outcomes. As an advocate for equitable care, she works to develop programs and services that can be incorporated into the clinic, with the goal of tackling the root causes of health differences in communities. Chu earned her medical degree at UCSF, where she also completed both a residency and a fellowship in general internal medicine. She has a master's degree in clinical and epidemiological research from UCSF and a master of public health degree from the University of California, Berkeley. Outside of work, Chu enjoys baking, hiking and reading. Dr. Chu is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Non-Alcoholic Fatty Liver Disease, Hepatitis B, Hepatitis, and COVID-19.
General Internal Medicine At Mount Zion
Dr. Damond B. Ng is an internal medicine specialist who provides primary and urgent care for adults. He serves as associate medical director of General Internal Medicine at Mount Zion. His professional interests include complex care coordination, multiple chronic disease management, diagnostic dilemmas and caring for underserved urban populations. Among the topics of Ng's research are graduate medical education, point-of-care ultrasound (using ultrasound imaging, as appropriate, to make assessments during visits to the clinic) and organizational management. Ng earned his medical degree from the David Geffen School of Medicine at the University of California, Los Angeles, where he then completed a residency in internal medicine with a focus on primary care. While at UCLA, he also earned a master of public health degree through the PRIME-LA Program, which focuses on health care leadership and advocacy for marginalized populations and communities with few resources. As a medical student, he was elected to the Gold Humanism Honor Society. Ng is a member of the Society of General Internal Medicine and American College of Physicians. In 2025, In 2025, Ng was awarded the Robert H. Crede Award for excellence in clinical care. Ng is a San Francisco native who volunteered at UCSF during high school. In his free time, he enjoys rooting for his local professional sports teams, live music, wandering through museums and building his Japanese whiskey collection. Dr. Ng is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Disseminated Tuberculosis, Hairy Cell Leukemia (HCL), Autoimmune Hemolytic Anemia, and Pulmonary Tuberculosis.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Dr. Charalambos (Babis) Andreadis specializes in bone marrow transplantation for adults and in treating Hodgkin's and non-Hodgkin's lymphoma, leukemia and multiple myeloma. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. His research, published widely in scientific journals, examines genetic and other factors that affect how patients respond to therapy, including degrees of drug toxicity. He also studies patient outcomes in these disorders. Andreadis earned his medical degree at Columbia University's Vagelos College of Physicians and Surgeons, and was elected to the Alpha Omega Alpha Honor Medical Society in 1998. He completed a residency at New York-Presbyterian Hospital and a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, where he joined the faculty in 2004. He also earned a master's degree in clinical epidemiology at the University of Pennsylvania, focusing on pharmacogenetics, the study of how genes impact an individual's response to medications. Dr. Andreadis is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
A leading expert in hematology-oncology, Dr. Thomas Martin is associate director of UCSF's myeloma program and director of the unrelated donor transplantation programs for adults at UCSF Medical Center. Martin is clinical research director of hematologic malignancies (blood cancers) at the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include developing treatments for myeloma and leukemia as well as expanding the use of bone marrow transplants. He has a special interest in umbilical cord blood transplants, and he is involved in efforts to improve outcomes for patients who have transplants from unrelated donors. Martin earned an undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine. After a medical residency at Harbor-UCLA Medical Center, he completed a fellowship in hematology-oncology at UCSF. In 1999, he joined MD Anderson Cancer Center as an assistant professor of medicine. In 2001, he returned to UCSF. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Dr. Lawrence D. Kaplan, a hematologist-oncologist, directs UCSF's lymphoma program. He is an international leader in the treatment of lymphoma and HIV-associated lymphoma. In his research, Kaplan is particularly interested in developing new treatments for lymphoma and the HIV-related form of this cancer. Kaplan earned his medical degree at the David Geffen School of Medicine at UCLA. He completed a residency in medicine at Boston Medical Center and completed a fellowship in hematology and oncology at UCSF. He joined UCSF in 1985. Kaplan's professional activities include serving on the Lymphoma Working Group of the AIDS Malignancy Consortium, a clinical trials group supported by the National Cancer Institute (NCI). He formerly chaired the group's steering committee. He also serves on the lymphoma committee of Alliance for Clinical Trials in Oncology, a national research group sponsored by the NCI. Dr. Kaplan is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Dr. Jeffrey L. Wolf is a hematologist with expertise in cancers of the bone marrow and blood, as well as in bone marrow transplantation to treat these cancers. His primary focus in both patient care and research is myeloma, the second most common blood cancer. He directs UCSF's Multiple Myeloma Program and the Stephen and Nancy Grand Multiple Myeloma Translational Initiative – a program to support the development of better treatments – at the UCSF Helen Diller Family Comprehensive Cancer Center. Wolf's current research interests are in measuring minimal residual disease in patients who have undergone successful treatment for myeloma, as the results are useful in predicting long-term survival. Wolf earned his medical degree at the University of Illinois College of Medicine at Chicago and completed a residency in medicine at the University of California, San Diego. He completed a fellowship in hematology and oncology at UCSF, followed by a bone marrow transplantation rotation at the Fred Hutchinson Cancer Research Center. In 1979, Wolf helped establish the bone marrow transplant program at the City of Hope Comprehensive Cancer Center in Duarte, California. In 1984, he helped establish the first bone marrow transplant unit based at a community hospital in the United States, at Alta Bates Summit Medical Center in Berkeley. He joined UCSF in 2007. Dr. Wolf is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Lloyd Damon is an Oncologist in San Francisco, California. Dr. Damon has been practicing medicine for over 44 years and is rated as an Advanced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Justin P. Fong, MD Private Practice
caring, good listener, dedicated, intelligent, compassionate, committed, healing and reassuring. Dr. Fong is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Glycogen Storage Disease Type 9, Glycogen Storage Disease Type 6, Glycogen Storage Disease Type 7, and Glycogen Storage Disease Type 13.
Robert W. Weber, MD Private Practice
Robert Weber is a Hematologist and an Oncologist in Daly City, California. Dr. Weber is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Weber is currently accepting new patients.
UCSF Medical Center
Lisa Rotenstein is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Rotenstein is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Severe Acute Respiratory Syndrome (SARS), Autoimmune Hemolytic Anemia, COVID-19, and Waldenstrom Macroglobulinemia.
University Of California San Francisco
Niharika Dixit is a Hematologist in San Francisco, California. Dr. Dixit is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Breast Cancer, and Hypereosinophilic Syndrome.
Birthmarks & Vascular Anomalies Center
Patricia Cornett is an Oncologist in San Francisco, California. Dr. Cornett is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Shwartzman Phenomenon, Venous Thromboembolism (VTE), Hereditary Ovalocytosis, Hereditary Elliptocytosis, and Bone Marrow Aspiration.
Univ Of California Home Care Serv
Kristen Hege is a Hematologist in San Francisco, California. Dr. Hege is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Hypereosinophilic Syndrome, and Acute Eosinophilic Pneumonia.
Office
Sandy Wong is a Hematologist in San Francisco, California. Dr. Wong has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Nina Shah is an Oncologist in San Francisco, California. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
San Francisco VA Medical Center
Lawrence Tierney is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Tierney is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Autoimmune Hemolytic Anemia and Sepsis.
ABSMC Comprehensive Cancer Center
Oleg Krijanovski is a Hematologist in Berkeley, California. Dr. Krijanovski is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Thrombocytopenia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Krijanovski is currently accepting new patients.
Cancer Center Burlingame
Dr. Kent Adler is an oncologist experienced in treating a variety of cancers, with particular expertise in lung and breast cancer. He believes three pillars form the strongest foundation to fight cancer: knowledge, communication and heart. Adler's research focuses on developing new therapies for lung cancer. Adler earned his medical degree from UCSF. He completed a residency in internal medicine at New York – Presbyterian/Weill Cornell Medical Center and a fellowship in medical oncology at Stanford University School of Medicine. A longtime advocate of multidisciplinary clinics for managing cancer, he co-founded one of the first multidisciplinary clinics for lung cancer on the West Coast while a faculty member at Stanford. Throughout his career, Adler has served in leadership positions, including as a board member of the Mills Peninsula Medical Group and Association of Northern California Oncologists. In his free time, Adler enjoys traveling, skiing and hiking with his wife, also a doctor, and their two adult children. A native of the Bay Area, he also loves the San Francisco Giants and almost anything related to baseball. Dr. Adler is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, and Large-Cell Immunoblastic Lymphoma.
Last Updated: 02/22/2026










